To understand where GLP1 is headed and what it means for manufacturers and retailers, we spoke with Leigh ODonnell, GLP1 expert and sponsor of Kantars Global GLP1 study, about the drivers behind its growth, how consumer behaviour is changing, and why this shift is only just beginning
Fiber intake should be managed carefully: too little increases constipation risk, but introducing fiber too rapidly while on semaglutide can cause bloating and gas that some patients find uncomfortable
Being intentional about recovery helps you maintain balance, build resilience and continue showing up for what matters most
The rationale for testing GLP-1 drugs in this context is growing
The available research suggests these medications may have neutral or potentially beneficial effects on cognitive function, though more definitive studies are needed